Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
4.900
+0.070 (1.45%)
At close: Jan 21, 2025, 4:00 PM
4.888
-0.012 (-0.24%)
After-hours: Jan 21, 2025, 6:57 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $9.81 million as of January 22, 2025. Its market cap has decreased by -58.11% in one year.
Market Cap
9.81M
Enterprise Value
17.10M
1-Year Change
-58.11%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $9.81M, a decrease of -83.25%. That is a compound annual growth rate of -42.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 9.67M | 11.81% |
| Dec 31, 2024 | 8.65M | -63.39% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.58B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |